+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biobank Management Systems Market By Sample Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994278
The biobank management systems market was valued at $2.1 billion in 2023, and is projected to reach $4.6 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033.

Biobank management system is an advanced platform designed to streamline the complex processes involved in managing biological samples and associated data. These systems ensure efficient collection, storage, and retrieval of biological specimens, which are essential for research and development in various fields, including genomics, personalized medicine, and drug discovery. In addition to storage management, these systems include features for managing consent from donors, handling data privacy, and supporting high-quality research by ensuring that samples are stored under optimal conditions. By automating many routine tasks, biobank management systems reduce errors, save time, and improve the efficiency of biobanks, making it easier for researchers and medical professionals to access the samples they need for studies and clinical trials.

Increase in number of biobanks, driven by surge in demand for biological samples in research and personalized medicine, is a significant factor fueling the growth of the global biobank management systems market. A study by the National Center for Biotechnology Information in 2021 highlighted that biobank activities have been growing significantly, with the number of biobanks increasing by approximately 10% annually. As genomic research expands, the need for sophisticated systems to manage and organize large volumes of biological data and samples has grown, further boosting the demand for biobank management systems. Moreover, surge in demand for personalized medicine is notably contributing toward the market growth. This is attributed to the fact that personalized medicine relies heavily on the availability and analysis of biological samples, increasing the need for efficient biobank management systems. A study published in The Lancet in 2023 projected a 25% rise in the adoption of biobank management systems due to the growing focus on personalized medicine and tailored treatments. Furthermore, the outbreak of the COVID-19 pandemic highlighted the importance of efficient biobanking systems to manage and distribute biological samples for research, which led to an increased focus on adopting biobank management systems, thereby augmenting the market growth. In addition, integration of AI and ML technologies in biobank management systems to enhance data analysis, predictive modeling, and automated decision-making is the current trend that is significantly augmenting the market growth. Adoption of cloud-based biobank management systems is on rise, offering scalable storage solutions, improved data accessibility, and enhanced collaboration among research teams, which is a key trend strengthening the market growth. However, limited awareness of the benefits of biobank management systems coupled with lack of expertise in implementing and maintaining these systems hinder the market growth. Despite advancements in security measures, concerns over data breaches and unauthorized access to sensitive biological data can deter institutions from fully adopting digital management systems. On the contrary, innovations in data management, automation, and cloud computing have enhanced the capabilities of biobank management systems, which are expected to offer lucrative opportunities for the expansion of the global market during the forecast period. In addition, rise in investments from government bodies, research institutions, and private companies in biobanking and related technologies are contributing to the expansion of the biobank management systems market.

The global biobank management systems industry is segmented into sample type, application, and region. By sample type, the market is divided into absorbable human tissue & organ samples, plant & animal samples, and microbial samples. On the basis of application, it is classified into regenerative medicine, life science research, clinical research, and environmental research. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By sample type, the human tissue & organ samples segment dominated the market, in terms of share, in 2023.

On the basis of application, the clinical research segment was the major shareholder in 2023.

Region wise, North America held the leading position in the market in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global biobank management systems market include Agilent Technologies, Inc., CloudLIMS Technologies Pvt. Ltd., AgileBio SARL, Modul-Bio, Autoscribe Informatics, Krishagni Solutions Pvt Ltd., Information Management Services, Inc, Technidata Inc, Qiagen N.V, and Azenta Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Sample Type

  • Absorbable Human Tissue Organ Samples
  • Plant Animal Samples
  • Microbial Samples

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
  • Environmental Research

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Key Market Players
  • Agilent Technologies, Inc.
  • CloudLIMS Technologies Pvt. Ltd.
  • AgileBio SARL
  • Modul-Bio
  • Autoscribe Informatics
  • Krishagni Solutions Pvt Ltd
  • Information Management Services, Inc
  • Technidata Inc
  • Qiagen N.V
  • Azenta Inc

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: BIOBANK MANAGEMENT SYSTEMS MARKET, BY SAMPLE TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Sample Type
4.2. Absorbable Human Tissue Organ Samples
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Plant Animal Samples
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Microbial Samples
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: BIOBANK MANAGEMENT SYSTEMS MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Regenerative Medicine
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Life Science Research
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Clinical Research
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Environmental Research
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: BIOBANK MANAGEMENT SYSTEMS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Sample Type
6.2.3. Market Size and Forecast, By Application
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Biobank Management Systems Market
6.2.5.1. Market Size and Forecast, By Sample Type
6.2.5.2. Market Size and Forecast, By Application
6.2.6. Canada Biobank Management Systems Market
6.2.6.1. Market Size and Forecast, By Sample Type
6.2.6.2. Market Size and Forecast, By Application
6.2.7. Mexico Biobank Management Systems Market
6.2.7.1. Market Size and Forecast, By Sample Type
6.2.7.2. Market Size and Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Sample Type
6.3.3. Market Size and Forecast, By Application
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Biobank Management Systems Market
6.3.5.1. Market Size and Forecast, By Sample Type
6.3.5.2. Market Size and Forecast, By Application
6.3.6. France Biobank Management Systems Market
6.3.6.1. Market Size and Forecast, By Sample Type
6.3.6.2. Market Size and Forecast, By Application
6.3.7. UK Biobank Management Systems Market
6.3.7.1. Market Size and Forecast, By Sample Type
6.3.7.2. Market Size and Forecast, By Application
6.3.8. Italy Biobank Management Systems Market
6.3.8.1. Market Size and Forecast, By Sample Type
6.3.8.2. Market Size and Forecast, By Application
6.3.9. Spain Biobank Management Systems Market
6.3.9.1. Market Size and Forecast, By Sample Type
6.3.9.2. Market Size and Forecast, By Application
6.3.10. Rest of Europe Biobank Management Systems Market
6.3.10.1. Market Size and Forecast, By Sample Type
6.3.10.2. Market Size and Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Sample Type
6.4.3. Market Size and Forecast, By Application
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Biobank Management Systems Market
6.4.5.1. Market Size and Forecast, By Sample Type
6.4.5.2. Market Size and Forecast, By Application
6.4.6. China Biobank Management Systems Market
6.4.6.1. Market Size and Forecast, By Sample Type
6.4.6.2. Market Size and Forecast, By Application
6.4.7. Australia Biobank Management Systems Market
6.4.7.1. Market Size and Forecast, By Sample Type
6.4.7.2. Market Size and Forecast, By Application
6.4.8. India Biobank Management Systems Market
6.4.8.1. Market Size and Forecast, By Sample Type
6.4.8.2. Market Size and Forecast, By Application
6.4.9. South Korea Biobank Management Systems Market
6.4.9.1. Market Size and Forecast, By Sample Type
6.4.9.2. Market Size and Forecast, By Application
6.4.10. Rest of Asia-Pacific Biobank Management Systems Market
6.4.10.1. Market Size and Forecast, By Sample Type
6.4.10.2. Market Size and Forecast, By Application
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Sample Type
6.5.3. Market Size and Forecast, By Application
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Biobank Management Systems Market
6.5.5.1. Market Size and Forecast, By Sample Type
6.5.5.2. Market Size and Forecast, By Application
6.5.6. Saudi Arabia Biobank Management Systems Market
6.5.6.1. Market Size and Forecast, By Sample Type
6.5.6.2. Market Size and Forecast, By Application
6.5.7. South Africa Biobank Management Systems Market
6.5.7.1. Market Size and Forecast, By Sample Type
6.5.7.2. Market Size and Forecast, By Application
6.5.8. Rest of LAMEA Biobank Management Systems Market
6.5.8.1. Market Size and Forecast, By Sample Type
6.5.8.2. Market Size and Forecast, By Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Agilent Technologies, Inc.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. CloudLIMS Technologies Pvt. Ltd.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. AgileBio SARL
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Modul-Bio
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Autoscribe Informatics
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Krishagni Solutions Pvt Ltd
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Information Management Services, Inc
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Technidata Inc
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Qiagen N.V
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Azenta Inc
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 2. Biobank Management Systems Market for Absorbable Human Tissue Organ Samples, by Region, 2024 - 2033 ($Billion)
Table 3. Biobank Management Systems Market for Plant Animal Samples, by Region, 2024 - 2033 ($Billion)
Table 4. Biobank Management Systems Market for Microbial Samples, by Region, 2024 - 2033 ($Billion)
Table 5. Global Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 6. Biobank Management Systems Market for Regenerative Medicine, by Region, 2024 - 2033 ($Billion)
Table 7. Biobank Management Systems Market for Life Science Research, by Region, 2024 - 2033 ($Billion)
Table 8. Biobank Management Systems Market for Clinical Research, by Region, 2024 - 2033 ($Billion)
Table 9. Biobank Management Systems Market for Environmental Research, by Region, 2024 - 2033 ($Billion)
Table 10. Biobank Management Systems Market, by Region, 2024 - 2033 ($Billion)
Table 11. North America Biobank Management Systems Market, by Country, 2024 - 2033 ($Billion)
Table 12. North America Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 13. North America Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 14. U.S. Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 15. U.S. Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 16. Canada Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 17. Canada Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 18. Mexico Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 19. Mexico Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 20. Europe Biobank Management Systems Market, by Country, 2024 - 2033 ($Billion)
Table 21. Europe Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 22. Europe Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 23. Germany Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 24. Germany Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 25. France Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 26. France Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 27. UK Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 28. UK Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 29. Italy Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 30. Italy Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 31. Spain Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 32. Spain Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 33. Rest of Europe Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 34. Rest of Europe Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 35. Asia-Pacific Biobank Management Systems Market, by Country, 2024 - 2033 ($Billion)
Table 36. Asia-Pacific Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 37. Asia-Pacific Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 38. Japan Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 39. Japan Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 40. China Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 41. China Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 42. Australia Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 43. Australia Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 44. India Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 45. India Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 46. South Korea Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 47. South Korea Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 48. Rest of Asia-Pacific Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 49. Rest of Asia-Pacific Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 50. LAMEA Biobank Management Systems Market, by Country, 2024 - 2033 ($Billion)
Table 51. LAMEA Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 52. LAMEA Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 53. Brazil Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 54. Brazil Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 55. Saudi Arabia Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 56. Saudi Arabia Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 57. South Africa Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 58. South Africa Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 59. Rest of LAMEA Biobank Management Systems Market, by Sample Type, 2024 - 2033 ($Billion)
Table 60. Rest of LAMEA Biobank Management Systems Market, by Application, 2024 - 2033 ($Billion)
Table 61. Agilent Technologies, Inc.: Key Executives
Table 62. Agilent Technologies, Inc.: Company Snapshot
Table 63. Agilent Technologies, Inc.: Operating Segments
Table 64. Agilent Technologies, Inc.: Product Portfolio
Table 65. Agilent Technologies, Inc.: Key Strategic Moves and Developments
Table 66. Cloudlims Technologies Pvt. Ltd.: Key Executives
Table 67. Cloudlims Technologies Pvt. Ltd.: Company Snapshot
Table 68. Cloudlims Technologies Pvt. Ltd.: Operating Segments
Table 69. Cloudlims Technologies Pvt. Ltd.: Product Portfolio
Table 70. Cloudlims Technologies Pvt. Ltd.: Key Strategic Moves and Developments
Table 71. Agilebio Sarl: Key Executives
Table 72. Agilebio Sarl: Company Snapshot
Table 73. Agilebio Sarl: Operating Segments
Table 74. Agilebio Sarl: Product Portfolio
Table 75. Agilebio Sarl: Key Strategic Moves and Developments
Table 76. Modul-Bio: Key Executives
Table 77. Modul-Bio: Company Snapshot
Table 78. Modul-Bio: Operating Segments
Table 79. Modul-Bio: Product Portfolio
Table 80. Modul-Bio: Key Strategic Moves and Developments
Table 81. Autoscribe Informatics: Key Executives
Table 82. Autoscribe Informatics: Company Snapshot
Table 83. Autoscribe Informatics: Operating Segments
Table 84. Autoscribe Informatics: Product Portfolio
Table 85. Autoscribe Informatics: Key Strategic Moves and Developments
Table 86. Krishagni Solutions Pvt Ltd.: Key Executives
Table 87. Krishagni Solutions Pvt Ltd.: Company Snapshot
Table 88. Krishagni Solutions Pvt Ltd.: Operating Segments
Table 89. Krishagni Solutions Pvt Ltd.: Product Portfolio
Table 90. Krishagni Solutions Pvt Ltd.: Key Strategic Moves and Developments
Table 91. Information Management Services, Inc.: Key Executives
Table 92. Information Management Services, Inc.: Company Snapshot
Table 93. Information Management Services, Inc.: Operating Segments
Table 94. Information Management Services, Inc.: Product Portfolio
Table 95. Information Management Services, Inc.: Key Strategic Moves and Developments
Table 96. Technidata Inc.: Key Executives
Table 97. Technidata Inc.: Company Snapshot
Table 98. Technidata Inc.: Operating Segments
Table 99. Technidata Inc.: Product Portfolio
Table 100. Technidata Inc.: Key Strategic Moves and Developments
Table 101. Qiagen N.V: Key Executives
Table 102. Qiagen N.V: Company Snapshot
Table 103. Qiagen N.V: Operating Segments
Table 104. Qiagen N.V: Product Portfolio
Table 105. Qiagen N.V: Key Strategic Moves and Developments
Table 106. Azenta Inc.: Key Executives
Table 107. Azenta Inc.: Company Snapshot
Table 108. Azenta Inc.: Operating Segments
Table 109. Azenta Inc.: Product Portfolio
Table 110. Azenta Inc.: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Biobank Management Systems Market, 2024 - 2033
Figure 2. Segmentation of Biobank Management Systems Market, 2024 - 2033
Figure 3. Top Investment Pocket in Biobank Management Systems Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalbiobank Management Systems Market
Figure 10. Global Biobank Management Systems Market Segmentation, by Sample Type
Figure 11. Biobank Management Systems Market for Absorbable Human Tissue Organ Samples, by Country, 2024 - 2033 ($Billion)
Figure 12. Biobank Management Systems Market for Plant Animal Samples, by Country, 2024 - 2033 ($Billion)
Figure 13. Biobank Management Systems Market for Microbial Samples, by Country, 2024 - 2033 ($Billion)
Figure 14. Global Biobank Management Systems Market Segmentation, by Application
Figure 15. Biobank Management Systems Market for Regenerative Medicine, by Country, 2024 - 2033 ($Billion)
Figure 16. Biobank Management Systems Market for Life Science Research, by Country, 2024 - 2033 ($Billion)
Figure 17. Biobank Management Systems Market for Clinical Research, by Country, 2024 - 2033 ($Billion)
Figure 18. Biobank Management Systems Market for Environmental Research, by Country, 2024 - 2033 ($Billion)
Figure 19. Top Winning Strategies, by Year, 2021-2023*
Figure 20. Top Winning Strategies, by Development, 2021-2023*
Figure 21. Top Winning Strategies, by Company, 2021-2023*
Figure 22. Product Mapping of Top 10 Players
Figure 23. Competitive Dashboard
Figure 24. Competitive Heatmap: Biobank Management Systems Market
Figure 25. Top Player Positioning, 2023
Figure 26. Agilent Technologies, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 27. Agilent Technologies, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 28. Agilent Technologies, Inc.: Revenue Share, by Region, 2023 (%)
Figure 29. Cloudlims Technologies Pvt. Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 30. Cloudlims Technologies Pvt. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 31. Cloudlims Technologies Pvt. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 32. Agilebio Sarl: Net Sales, 2021-2023 ($Billion)
Figure 33. Agilebio Sarl: Revenue Share, by Segment, 2023 (%)
Figure 34. Agilebio Sarl: Revenue Share, by Region, 2023 (%)
Figure 35. Modul-Bio: Net Sales, 2021-2023 ($Billion)
Figure 36. Modul-Bio: Revenue Share, by Segment, 2023 (%)
Figure 37. Modul-Bio: Revenue Share, by Region, 2023 (%)
Figure 38. Autoscribe Informatics: Net Sales, 2021-2023 ($Billion)
Figure 39. Autoscribe Informatics: Revenue Share, by Segment, 2023 (%)
Figure 40. Autoscribe Informatics: Revenue Share, by Region, 2023 (%)
Figure 41. Krishagni Solutions Pvt Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 42. Krishagni Solutions Pvt Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 43. Krishagni Solutions Pvt Ltd.: Revenue Share, by Region, 2023 (%)
Figure 44. Information Management Services, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 45. Information Management Services, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 46. Information Management Services, Inc.: Revenue Share, by Region, 2023 (%)
Figure 47. Technidata Inc.: Net Sales, 2021-2023 ($Billion)
Figure 48. Technidata Inc.: Revenue Share, by Segment, 2023 (%)
Figure 49. Technidata Inc.: Revenue Share, by Region, 2023 (%)
Figure 50. Qiagen N.V: Net Sales, 2021-2023 ($Billion)
Figure 51. Qiagen N.V: Revenue Share, by Segment, 2023 (%)
Figure 52. Qiagen N.V: Revenue Share, by Region, 2023 (%)
Figure 53. Azenta Inc.: Net Sales, 2021-2023 ($Billion)
Figure 54. Azenta Inc.: Revenue Share, by Segment, 2023 (%)
Figure 55. Azenta Inc.: Revenue Share, by Region, 2023 (%)

Companies Mentioned

Key Market Players in the Biobank Management Systems Market include:
  • Agilent Technologies, Inc.
  • CloudLIMS Technologies Pvt. Ltd.
  • AgileBio SARL
  • Modul-Bio
  • Autoscribe Informatics
  • Krishagni Solutions Pvt Ltd
  • Information Management Services, Inc
  • Technidata Inc
  • Qiagen N.V
  • Azenta Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information